BOK Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

BOK Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$73.4K	Hold	464	–	–	﹤0.01%	798
2026 Q1	$59.3K	Hold	464	–	–	﹤0.01%	809
2025 Q4	$56.6K	Hold	464	–	–	﹤0.01%	828
2025 Q3	$46.5K	Sell	464 -26	-5%	-$2.34K	﹤0.01%	848
2025 Q2	$40.6K	Hold	490	–	–	﹤0.01%	853
2025 Q1	$39.7K	Sell	490 -150	-23%	-$13.4K	﹤0.01%	848
2024 Q4	$57.2K	Sell	640 -200	-24%	-$19.4K	﹤0.01%	802
2024 Q3	$81.2K	Sell	840 -550	-40%	-$54K	﹤0.01%	772
2024 Q2	$129K	Buy	1,390 +550	+65%	+$49.3K	﹤0.01%	791
2024 Q1	$78.8K	Buy	840 +350	+71%	+$32.5K	﹤0.01%	810
2023 Q4	$43.8K	Hold	490	–	–	﹤0.01%	819
2023 Q3	$32.5K	Hold	490	–	–	﹤0.01%	803
2023 Q2	$40.8K	Sell	490 -370	-43%	-$30.9K	﹤0.01%	817
2023 Q1	$65.5K	Buy	+860	New	+$71.4K	﹤0.01%	809
2017 Q4	–	Sell	-100	Closed	-$9K	–	1134
2017 Q3	$9K	Buy	+100	New	+$8.02K	﹤0.01%	1092
2015 Q3	–	Sell	-2,685	Closed	-$226K	–	892
2015 Q2	$226K	Hold	2,685	–	–	0.01%	778
2015 Q1	$202K	Buy	+2,685	New	+$188K	0.01%	781

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BOK Financial's XBI Position: Q2 2026 in Review

BOK Financial held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 464 shares worth $73.4K. The position accounts for ﹤0.01% of the portfolio, ranked #798.

BOK Financial first reported a position in XBI in Q1 2015 and has held it in 17 quarters since. The position peaked at $226K in Q2 2015. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

BOK Financial held 464 shares of State Street SPDR S&P Biotech ETF worth $73.4K as of Q2 2026.
BOK Financial left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of BOK Financial's portfolio in Q2 2026, its #798 holding.
BOK Financial first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and has held it in 17 quarters since.
BOK Financial's State Street SPDR S&P Biotech ETF position peaked at $226K in Q2 2015.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.